Phenotypic and Genotypic Profiling of MDM2, Respective to the TP53 Genetic Status, in Diffuse Large B-cell Lymphoma Patients Treated With Rituximab-CHOP Immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
Titel:
Phenotypic and Genotypic Profiling of MDM2, Respective to the TP53 Genetic Status, in Diffuse Large B-cell Lymphoma Patients Treated With Rituximab-CHOP Immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
Auteur:
Xu-Monette, Zijun Y. Møller, Michael B. Tzankov, Alexander Montes-Moreno, Santiago Hu, Wenwei Manyam, Ganiraju C. Kristensen, Louise Fan, Lei Visco, Carlo Dybkær, Karen Chiu, April Tam, Wayne Zu, Youli Bhagat, Govind Richards, Kristy L. Hsi, Eric D. Choi, William W.L. van Krieken, J. Han Huang, Qin Huh, Jooryung Ai, Weiyun Ponzoni, Maurilio Ferreri, Andrés J.M. Wu, Lin Zhao, Xiaoying Bueso-Ramos, Carlos E. Wang, Sa A. Go, Ronald S. Li, Yong Winter, Jane N. Piris, Miguel A. Medeiros, L. Jeffrey Young, Ken H.